Prolytix

Prolytix, formerly Haematologic Technologies, has 30+ years of experience in protein chemistry, which ensures our team will identify and solve the challenges of your large molecule product. Our services in research and development, characterization by high-resolution mass spectrometry (HRMS), GxP testing, and custom collection devices assist clients worldwide. Using an agile, consultative approach, we support your products development from discovery through GMP release. With our proven CMC and regulatory expertise from IND through BLA to our accessible, attentive, and seasoned team, Prolytix is the go-to partner for protein therapeutic projects from routine to complex. For advanced protein development, go with...

Blood coagulation proteins,coagulation antibodies,factor deficient plasma,blood collection tubes,coagulation,biotherapeutics,analytics,large molecule analytics,biologics,large molecule analytics,assay development,immunoassays,thrombin generation assays,assessment of hemostatic risk,anti-drug antibody testing,host cell protein mitigation,stability and release,gmp stability and release of biologics,high resolution mass spectrometry,peptide mapping,intact protein characterization,de-novo antibody sequencing,capsid characterization,clone selection,orthogonal methods for hcp detection,advanced biomarker assay development and validation,biologics manufacturing support,ivig assay experts,quantitative wester blot assays,custom collection devices,complete de nobo assay development,plasma fractionation and purification,and critical reagent manufacturing

Prolytix operates in the Biotechnology research industry.

Prolytix's revenue is 11m - 100m

Prolytix has 11 - 50 employees.